Scientists Call For Safety Testing of Aluminum Based Vaccine Adjuvants

• The Facts:
  A new paper recently published a paper in the Journal of Trace Elements in Medicine and Biology calls into question the safety of aluminum adjuvants in vaccines.
  
• Reflect On:
  Why have there been no studies by regulatory agencies in conjunction with independent scientists to see where vaccine ingredients travel to in the body after the are injected? Why no appropriate safety testing for the aluminum vaccine adjuvant?
  

Described general knowledge on aluminum (Al) exposure, kinetics and toxicity but made very little effort to delineate the scientific questions specifically related to Al adjuvants in vaccines. Instead of representing the bulk of their review, the subject of Al adjuvants covered no more than one third of the 3 page-text. Numerous important papers on the topic were omitted, i.e. 20 years of scientific publications in clinical, post-mortem, in vitro and in vivo experimental studies published by independent research teams, worldwide experts in this topic, were simply omitted.

When you inject aluminum, it goes into a different compartment of your body. It doesn’t come into that same mechanism of excretion. So, and of course it can’t because that’s the whole idea of aluminum adjuvants, aluminum adjuvants are meant to stick around and allow that antigen to be presented over and over and over again persistently, otherwise you wouldn’t put an adjuvant in in the first place. It can’t be inert, because if it were inert it couldn’t do the things it does. It can’t be excreted because again it couldn’t provide that prolonged exposure of the antigen to your immune system. – Dr. Christopher Shaw –  Canadian neuroscientist and professor of ophthalmology at the University of British Columbia (source)

Intramuscular injection of alum-containing vaccine was associated with the appearance of aluminum deposits in distant organs, such as spleen and brain where they were still detected one year after injection. Both fluorescent materials injected into muscle translocated to draining lymph nodes (DLNs) and thereafter were detected associated with phagocytes in blood and spleen. Particles linearly accumulated in the brain up to the six-month endpoint; they were first found in perivascular CD11b+ cells and then in microglia and other neural cells. DLN ablation dramatically reduced the biodistribution. Cerebral translocation was not observed after direct intravenous injection, but significantly increased in mice with chronically altered blood-brain-barrier. Loss/gain-of-function experiments consistently implicated CCL2 in systemic diffusion of Al-Rho particles captured by monocyte-lineage cells and in their subsequent neurodelivery. Stereotactic particle injection pointed out brain retention as a factor of progressive particle accumulation…

Evidence that aluminum-coated particles phagocytozed in the injected muscle and its draining lymph nodes can disseminate within phagocytes throughout the body and slowly accumulate in the brain further suggests that alum safety should be evaluated in the long term.

Because Gatti and Montanari had taken their research of nanodust and nanoparticles, from in-vivo (performed in a living organism) and in-vitro (performed in a test tube) to what unseen contamination might reside in vaccines in 2016, they came under the microscope of the United States, European, and Italian authorities. They had touched the third rail of medicine. They had crossed the no-go zone with the purported crime being scientific research and discovery. By finding nano-contamination in random vaccines, Gatti and Montanari revealed, for the first time, what no one knew: Vaccines had more than aluminum salts adjuvants, Polysorbate-80, and other inorganic chemicals in them, they also harbored stainless steel, tungsten, copper, and other metals and rare elements that don’t belong in shots given to fetuses, pregnant women, newborns, babies and toddlers developing their lungs, immune and nervous systems.

When we add an adjuvant, it’s because it is essential. We do not add adjuvants to vaccines because we want to do so, but when we add them it adds to the complexity. And I give courses every year on ‘how do you develop vaccines’ and ‘how do you make vaccines’ and the first lesson is, while you are making your vaccine, if you can avoid using an adjuvant, please do so. Lesson two is, if you’re going to use an adjuvant, use one that has a history of safety, and lesson three is, if you’re not going to do that, think very carefully.

Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. (source)